Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as OPTINOSE™ FLUTICASONE
OPTINOSE FLUTICASONE · 1 trial · 1 indication
Part 2
| Arm | Type | Description |
|---|---|---|
| Flovent® HFA 440µg | ACTIVE_COMPARATOR | Flovent® HFA (fluticasone propionate) Inhalation Aerosol 440 µg |
| OPTINOSE™ FLUTICASONE 400µg intranasal | EXPERIMENTAL | OPTINOSE™ FLUTICASONE, single dose of 400 µg intranasally |
| Name | Type | Description |
|---|---|---|
| Flovent HFA | DRUG | - |
| OPTINOSE™ FLUTICASONE | DRUG | - |
Inclusion Criteria: 1. Male or female subjects' ages 18 to 55 years, inclusive, at screening. 2. Have a body mass index of 18 to 32 kg/m2, inclusive, and a body weight of not less than 52 kg for males and 45 kg for females. 3. Otherwise healthy mild to moderate asthmatic (Part 2) with no clinically...